Role of Udumabr Ghanvati and Udumbar Ointment in white discharge.

A comparative clinical study to evaluate the efficacy of Udumabar Ghanvati & Udumbar Ointment in the management Of Pittala Yonivyapad W.S.R. To Vulvovaginitis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/11/010572

Enrollment

Registered

2017-11-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- vulvovaginitis/pittala yonivaypad

Interventions

Intervention1: udumabar ghanvati: Dose: 500 mg Frequency: twicw a day Duration: 21 days Control Intervention1: not applicable: not applicable Control Intervention2: Udumbar Ointment: dose: 5 gm durati

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with symptoms of acute and chronic inflammation of external genital organs and vaginal canal. 2.Patient presenting with Yoni Strava, Yoni Daha And Yoni Vedna .

Exclusion criteria

Exclusion criteria: 1. Patients presenting with acute and chronic inflammatory growths and UTI . 2. Patients with PUO (pyrexia of unknown origin). 3. Patients with Systemic diseases- bleeding disorders, diabetes mellitus, hypertension, T.B, heart disease, thyroid dysfunction, malignancies , hepatitis . 4. Patients with STD such as HIV, syphillis, gonnorrhea, herpes genitalis, molluscum contagiosum, scabies pediculosis pubis, etc . 5. Patients with any benign and malignant growth.

Design outcomes

Primary

Measure	Time frame
To Compare The Effect Of Udumbar Ghanvati and Udumbar Ointment in VaginitisTimepoint: 51 days	—

Secondary

Measure	Time frame
Exacerbation of sign and symptomsTimepoint: 4 days	—

Countries

India

Contacts

Public Contactpravesh tomar

Rishikul Campus, Uttrakhand Ayurveda University

praveshtomarlal@rediffmail.com9557639649

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026